Your browser doesn't support javascript.
loading
Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy.
Di Martino, Maria Teresa; Zazzeroni, Francesca; Donadelli, Massimo; Chiodoni, Claudia; Caraglia, Michele; Scotlandi, Katia; Meschini, Stefania; Leonetti, Carlo.
Afiliação
  • Di Martino MT; Dept. of Experimental and Clinical Medicine, University of Catanzaro "Magna Graecia", Catanzaro, Italy. teresadm@unicz.it.
  • Zazzeroni F; Dept. of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Donadelli M; Dept. of Neurosciences, Biomedicine and Movement Sciences, Section of Biochemistry, University of Verona, Verona, Italy.
  • Chiodoni C; Molecular Immunology Unit, Dept. of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Caraglia M; Department of Biochemistry, Biophysics and General Pathology, University of Campania "L. Vanvitelli", Naples, Italy.
  • Scotlandi K; Experimental Oncology Lab, CRS Development of Biomolecular Therapies, Orthopaedic Rizzoli Institute, Bologna, Italy.
  • Meschini S; National Center for Drug Research and Evaluation, National Institute of Health, Rome, Italy.
  • Leonetti C; UOSD SAFU, Regina Elena National Cancer Institute, Rome, Italy.
J Exp Clin Cancer Res ; 37(1): 48, 2018 Mar 05.
Article em En | MEDLINE | ID: mdl-29506548
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comunicação Celular / Neoplasias Hematológicas / Microambiente Tumoral / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comunicação Celular / Neoplasias Hematológicas / Microambiente Tumoral / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article